Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular ...

DUBAI, United Arab Emirates--(BUSINESS WIRE)--Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for Spinal Muscular Atrophy (SMA) to Hulus, a ...

The newly licensed intrathecal gene therapy expands life-changing treatment options for children and adults affected by ...

The UAE-based Medcare Women & Children Hospital has successfully administered a pioneering intrathecal gene therapy for spinal muscular atrophy (SMA) to a three-year-old patient from Turkey. This ...

The newly licensed intrathecal gene therapy expands life-changing treatment options for children and adults affected by SMA Medcare Women Children Hospital has successfully administered a pioneering ...

Licensed intrathecal gene therapy enhances treatment for Spinal Muscular Atrophy patients ...

Childhood cancer survivors have an elevated lifetime risk for meningioma, with the greatest risks among those who received ...

Highlights from the 2025 Muscular Dystrophy Association (MDA) Conference include clinical updates, expert insights, and ...

The FDA has relaxed a clinical hold on clinical trials of Novartis' intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway.